Dataset from A Phase 1, Open-Label, Randomized, Three-Way Crossover Study Evaluating the Relative Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009886
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the oral bioavailability of two new tablet
formulations of TAK-385 (T4 Formulation B and T4 Formulation C) under fasted and fed
conditions, relative the T2 Formulation tablet; and to estimate the effect of food on the
pharmacokinetics (PK) of a single oral dose of the T4 Formulation B tablet and the T4
Formulation C tablet.
创建时间：
2025-02-10
